These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11572140)

  • 1. Clinicopathologic aspects of bacterial agents.
    Martin GJ; Marty AM
    Clin Lab Med; 2001 Sep; 21(3):513-48, ix. PubMed ID: 11572140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J; Zaki SR
    J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism.
    Greenfield RA; Bronze MS
    Curr Opin Investig Drugs; 2004 Feb; 5(2):135-40. PubMed ID: 15043386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diseases caused by bacteria and rickettsia in biological warfare and bioterrorism].
    Bojić I; Vukadinov J; Minić S
    Med Pregl; 2007; 60(3-4):195-7. PubMed ID: 17853736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary disease from biological agents: anthrax, plague, Q fever, and tularemia.
    Daya M; Nakamura Y
    Crit Care Clin; 2005 Oct; 21(4):747-63, vii. PubMed ID: 16168313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparedness for a bioterrorism event in Alaska. Part 1: Detection and identification of a biologic event.
    Funk EA
    Alaska Med; 2000; 42(4):101-13. PubMed ID: 14593880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial agents used for bioterrorism.
    Horn JK
    Surg Infect (Larchmt); 2003; 4(3):281-7. PubMed ID: 14588163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial pathogens as biological weapons and agents of bioterrorism.
    Greenfield RA; Drevets DA; Machado LJ; Voskuhl GW; Cornea P; Bronze MS
    Am J Med Sci; 2002 Jun; 323(6):299-315. PubMed ID: 12074485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical recognition and management of patients exposed to biological warfare agents.
    Franz DR; Jahrling PB; Friedlander AM; McClain DJ; Hoover DL; Bryne WR; Pavlin JA; Christopher GW; Eitzen EM
    JAMA; 1997 Aug; 278(5):399-411. PubMed ID: 9244332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological agents: weapons of warfare and bioterrorism.
    Broussard LA
    Mol Diagn; 2001 Dec; 6(4):323-33. PubMed ID: 11774197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization against potential biological warfare agents.
    Cieslak TJ; Christopher GW; Kortepeter MG; Rowe JR; Pavlin JA; Culpepper RC; Eitzen EM
    Clin Infect Dis; 2000 Jun; 30(6):843-50. PubMed ID: 10880299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnostic techniques for use in response to bioterrorism.
    Firmani MA; Broussard LA
    Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Germs employed as biological weapons].
    Meyer CG; May J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Sep; 37(9):538-46. PubMed ID: 12215940
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular recognition of biowarfare agents using micromechanical sensors.
    Ji HF; Yang X; Zhang J; Thundat T
    Expert Rev Mol Diagn; 2004 Nov; 4(6):859-66. PubMed ID: 15525227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological warfare. I. Anthrax, plague, tularemia].
    Christ W; Stein H
    Med Monatsschr Pharm; 2002 Dec; 25(12):406-17. PubMed ID: 12522911
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anthrax--an old disease becomes topical: cutaneous anthrax and the eye].
    Kalpadakis P; Rudolph G; Stefani FH; Kampik A
    Ophthalmologe; 2003 Mar; 100(3):216-21. PubMed ID: 12640551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Armies of pestilence: CNS infections as potential weapons of mass destruction.
    Hart BL; Ketai L
    AJNR Am J Neuroradiol; 2015 Jun; 36(6):1018-25. PubMed ID: 25477355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current epidemiology of selected bacterial zoonoses].
    Weber A
    Gesundheitswesen; 2004 Feb; 66 Suppl 1():S26-30. PubMed ID: 14770334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteria as agents of biowarfare. How to proceed when the worst is suspected.
    Tjaden JA; Lazarus AA; Martin GJ
    Postgrad Med; 2002 Aug; 112(2):57-60, 63-4, 67-70. PubMed ID: 12198754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical recognition and management of patients exposed to biological warfare agents.
    Franz DR; Jahrling PB; McClain DJ; Hoover DL; Byrne WR; Pavlin JA; Christopher GW; Cieslak TJ; Friedlander AM; Eitzen EM
    Clin Lab Med; 2001 Sep; 21(3):435-73. PubMed ID: 11572137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.